
Volition’s Nu.Q Vet Assay Detects Two Common Canine Cancers
- Share
- Tweet
- Share on Facebook
- Share

A short video, featuring Dr. Heather Wilson-Robles, detailing Volition’s new discovery data in canine cancer. Using a single Nu.Q® assay at 90% specificity detected almost 70% of canine hemangiosarcoma and lymphoma.
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields